z-logo
open-access-imgOpen Access
Fucoidan cures infection with both antimony-susceptible and -resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants
Author(s) -
Sudeshna Kar,
Gunjan Sharma,
P.K. Das
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq502
Subject(s) - leishmania donovani , macrophage , microbiology and biotechnology , fucoidan , leishmania , biology , virology , immunology , leishmaniasis , in vitro , visceral leishmaniasis , parasite hosting , biochemistry , polysaccharide , world wide web , computer science
The aim of this study was to evaluate and characterize the antileishmanial efficacy of fucoidan, a polyanionic sulphated polysaccharide from brown algae, in experimental infections of BALB/c mice with antimony-susceptible (AG83) and -resistant (GE18ER) Leishmania donovani.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom